Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1673.55
4.35 (0.26%)
< Home < Back

Sun Pharmaceutical acquires Pharmalucence through its subsidiary

Date: 16-07-2014

Sun Pharmaceutical Industries has acquired Pharmalucence Inc., through one of its subsidiary. Pharmalucence has sterile injectable capacity in the US supported by strong R&D capabilities.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.